EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study



A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study



American Journal of Clinical Pathology 144(5): 817-822



Epstein-Barr virus (EBV)-induced lymphoproliferative disorders (LPDs) are lymphoid proliferations arising as a result of the loss of an effective EBV-specific cytotoxic T-cell response. LPDs may occur for primary or acquired impairment of the immune system, as well as in some persons without documented immunodeficiency. In this article, we describe the case of a human immunodeficiency virus-positive patient affected by an EBV-LPD of the stomach who developed a nodal diffuse large B-cell lymphoma with complex morphologic and molecular features. GeneScan analysis of the gastric specimen identified two different heavy-chain immunoglobulin gene (IGH) rearrangements characterized by a dominant peak of 285 base pairs (bp) in length and a smaller peak of 266 bp in length. In the lymph node sample, IGH evaluation also demonstrated two different peaks; however, the main peak corresponded to the minor peak detected in the EBV-LPD specimen at the diagnosis. In addition, a monoclonal immunoglobulin light chain gene (IGL) rearrangement was also found. We also demonstrated that the major peak in the stomach corresponded to the EBV-positive population observed in the histologic sections. This case may provide additional insights to better understanding the "hit-and-run" role for EBV in lymphomagenesis. However, we could not exclude that our findings represent the co-occurrence of two unrelated B-cell neoplasms rather than a progression from an EBV-positive neoplasm to an EBV-negative one.

(PDF emailed within 0-6 h: $19.90)

Accession: 057068226

Download citation: RISBibTeXText

PMID: 26486748

DOI: 10.1309/AJCP2G0VKTKPNPRR



Related references

Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. Journal of Pediatrics 120(2 Pt 1): 228-232, 1992

Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 58(3): 317-324, 1994

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas. Blood 88(1): 242-251, 1996

Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 56(6): 1394-1398, 1993

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplantation (Baltimore) 68(10): 1517-1525, Nov 27, 1999

Epstein-Barr virus -induced lymphoproliferative disorders manifesting as plasmacytomas. Laboratory Investigation 68(1): 96A, 1993

Epstein barr virus induced lymphoproliferative disorders in scid hu chimeric mice. Touraine, J L , Et Al (Ed ) Transplantation And Clinical Immunology, Vol Xxiii Virus And Transplantation; Proceedings Of The Twenty-Third International Course, Lyon, France, June 3-5, Xiii+434p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 237-245, 1991

Primary immunodeficiency diseases and Epstein-Barr virus-induced lymphoproliferative disorders. Acta Paediatrica Japonica 34(4): 385-392, 1992

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders. Biomedicine & PharmacoTherapy 39(2): 52-58, 1985

Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case. Journal of the Formosan Medical Association 93(4): 332-336, 1994

Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report. Journal of Clinical and Experimental Hematopathology 52(3): 205-209, 2013

Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report. Human Pathology 44(12): 2849-2852, 2014

Epstein-Barr Virus Induced Lymphoproliferative Disorders Following Hematopoietic Stem Cell Transplantation in Pediatric Patients. Blood 100(11): Abstract No 2480, November 16, 2002